Funded Tech Companies
Twentyeight-Seven Therapeutics
Looking for the VC firms that backed Twentyeight-Seven Therapeutics? Osage Partners, Sofinnova Ventures and Astellas Venture Capital invested in this biopharmaceutical company.
Company Overview
Company Name
Twentyeight-Seven Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
490 Arsenal Way 100B
Watertown, MA 02472
USA
Watertown, MA 02472
USA
Phone
Website
Email Address
Company Background Information
Overview
Twentyeight-Seven Therapeutics is a focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
5/10/2019
Financing History
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kazumi Shiosaki
Chief Scientific Officer
Shomir Ghosh
VP - Bus. Development
Reid Leonard
VP - R & D
Ross Stein
Company Investors
- Osage Partners
- Sofinnova Ventures (Henrijette Richter)
- Astellas Venture Capital
- Johnson & Johnson Development Corporation
- Novartis Venture Fund (Michal Silverberg)
- Longwood Fund
- MPM Capital (Luke Evnin)
- Vertex Ventures HC (Carolyn Ng)
Browse more funded tech companies:
Share this article
About Our VC Deals Database
Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs